Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS20040015041 A1
Type de publicationDemande
Numéro de demandeUS 10/197,973
Date de publication22 janv. 2004
Date de dépôt18 juil. 2002
Date de priorité18 juil. 2002
Autre référence de publicationUS7662085, US20060009676, WO2004008941A2, WO2004008941A3
Numéro de publication10197973, 197973, US 2004/0015041 A1, US 2004/015041 A1, US 20040015041 A1, US 20040015041A1, US 2004015041 A1, US 2004015041A1, US-A1-20040015041, US-A1-2004015041, US2004/0015041A1, US2004/015041A1, US20040015041 A1, US20040015041A1, US2004015041 A1, US2004015041A1
InventeursDavid Melvin
Cessionnaire d'origineThe University Of Cincinnati
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Protective sheath apparatus and method for use with a heart wall actuation system for the natural heart
US 20040015041 A1
Résumé
An actuation system for assisting the operation of the natural heart includes a framework for interfacing with a natural heart and which is coupled with tissue of the heart. An actuator element is adapted to be coupled to the framework and is configured for extending along a portion of a heart wall exterior surface. The actuator element is operable for deforming the portion of the heart wall to effect a reduction in the volume of the heart. A protective sheath is configured to extend along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage by the actuator element. The protective sheath is flexible and operable to transmit, to the heart wall portion, a force thereon by the actuator element for indenting the heart wall portion.
Images(4)
Previous page
Next page
Revendications(31)
What is claimed is:
1. An actuation system for assisting the operation of the natural heart, the actuation system comprising:
an actuator element configured for extending proximate a portion of a heart wall exterior surface and operable for indenting the portion of the heart wall to effect a reduction in the volume of the heart;
a protective sheath configured to extend along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage by the actuator element;
the protective sheath being flexible and operable to transmit, to the heart wall portion, a force thereon by the actuator element for indenting the heart wall portion.
2. The actuation system of claim 1 further comprising a framework for interfacing with the heart and including elements configured for being anchored to the heart.
3. The actuation system of claim 1 wherein the protective sheath is porous.
4. The actuation system of claim 1 wherein the protective sheath comprises:
a plurality of interlocked elements.
5. The actuation system of claim 4 wherein interlocked elements of the plurality are formed of at least one of stainless steel, titanium, an abrasion-resistant polymer, a ceramic, nickel-titanium alloys, shape memory materials, and a combination of same.
6. The actuation system of claim 1 wherein the interlocked elements form ring-shaped structures.
7. The actuation system of claim 1 wherein the protective sheath comprises:
a fabric jacket;
a plurality of studs interspersed throughout the fabric and having stud surfaces generally coextensive with surfaces of the fabric.
8. The actuation system of claim 7 wherein said studs have rounded surfaces on at least one surface of the fabric.
9. The actuation system of claim 7 wherein the studs are formed of at least one of stainless steel, titanium, a ceramic, an abrasion-resistant polymer and a combination of same.
10. The actuation system of claim 7 wherein the fabric jacket is formed of at least one of a polyester, PTFE, a cellulose, polyethylene, and polyglycolic acid.
11. The actuation system of claim 1 wherein the protective sheath comprises:
a net of woven, abrasion-resistant cords.
12. The actuation system of claim 11 wherein the cords are formed of at least one of stainless steel, titanium, an abrasion-resistant polymer, a ceramic, nickel-titanium alloys, shape memory material, and a combination of same.
13. The actuation system of claim 1 wherein the actuator element comprises:
an actuator band extending along a portion of a heart wall, the actuator band being selectively movable between an actuated state and a relaxed state and operable, when in the actuated state, to assume a predetermined shape and thereby indent the protective sheath and a portion of the heart wall to effect a reduction in the volume of the heart.
14. The actuation system of claim 13 wherein the actuator band includes a plurality of juxtaposed blocks configured to be drawn together and to cooperate with each other, when drawn together, to assume the predetermined shape.
15. The actuation system of claim 7 wherein at least some of the cords extend in a direction; the actuator element moving in a direction generally parallel to said cord direction.
16. The actuation system of claim 2 wherein said protective sheath is anchored to said framework.
17. The actuation system of claim 1 wherein said protective sheath is anchored to said actuator element.
18. The actuation system of claim 1 wherein said protective sheath is configured for being anchored to tissue of a heart.
19. The actuation system of claim 2 wherein the actuator element is coupled to the framework.
20. A method for assisting the operation of the natural heart, the method comprising:
positioning an actuator element to extend along a portion of a heart wall exterior surface;
positioning a flexible protective sheath along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage;
indenting the sheath and portion of the heart wall to effect a reduction in the volume of the heart.
21. The method of claim 20 further comprising anchoring a framework to tissue of a natural heart and coupling the actuator element to the framework.
22. The method of claim 21 further comprising anchoring a framework having at least one internal element coupled to tissue inside of the heart and at least one external element coupled to an outside surface of the heart.
23. The method of claim 20 further comprising positioning a protective sheath having a plurality of interlocked rings along the heart wall.
24. The method of claim 20 further comprising positioning, along the heart wall, a protective sheath having a fabric jacket and plurality of studs interspersed throughout the fabric and having stud surfaces generally coextensive with surfaces of the fabric.
25. The method of claim 20 further comprising positioning a protective sheath including having a net of woven, abrasion-resistant cords along the heart wall.
26. The method of claim 20 further comprising positioning an actuator band to extend along a portion of a heart wall, and manipulating the actuator band so the band takes a predetermined shape and indent the protective sheath and a portion of the heart wall.
27. The method of claim 26 wherein the actuator band includes a plurality of juxtaposed blocks, the method further comprising drawing the blocks together to make the band assume the predetermined shape.
28. The method of claim 25 wherein at least some of the cords extend in a direction, the method comprising indenting the sheath and heart wall portion by moving the actuator element in a direction generally parallel to the cord direction.
29. The method of claim 20 further comprising anchoring the protective sheath to tissue of the heart.
30. The method of claim 21 further comprising anchoring the protective sheath to the framework.
31. The method of claim 20 further comprising anchoring the protective sheath to the actuator element.
Description
    RELATED APPLICATIONS
  • [0001]
    This application is related to an application entitled “A Flexible, Torsionable Cardiac Framework for Heart Wall Actuation of the Natural Heart, filed on even date herewith, which is incorporated herein by reference in its entirety.
  • FIELD OF THE INVENTION
  • [0002]
    This invention relates generally to assisting the natural heart in operation by actuating a wall of the natural heart, and more specifically to facilitating such actuation without damage to the heart tissue.
  • BACKGROUND OF THE INVENTION
  • [0003]
    The natural human heart and accompanying circulatory system are critical components of the human body and systematically provide the needed nutrients and oxygen for operation of the body. As such, the proper operation of the circulatory system, and particularly, the proper operation of the heart, are critical in the life, health and well-being of a person. A physical ailment or condition which compromises the normal and healthy operation of the heart can therefore be particularly critical and may result in a condition which must be medically remedied.
  • [0004]
    More specifically, the natural heart, or rather the cardiac tissue of the heart, can degrade for various reasons to a point where the heart can no longer provide sufficient circulation of blood for maintaining the health of a patient at a desirable level. In fact, the heart may degrade to the point of failure and thereby may not even be able to sustain life. To address the problem of a failing natural heart, solutions are offered to provide ways in which circulation of blood might be maintained. Some solutions involve replacing the heart. Other solutions are directed to maintaining operation of the existing heart.
  • [0005]
    One such solution has been to replace the existing natural heart in a patient with an artificial heart or a ventricular assist device. In using artificial hearts and/or assist devices, a particular problem stems from the fact that the materials used for the interior lining of the chambers of an artificial heart are in direct contact with the circulating blood. Such contact may enhance undesirable clotting of the blood, may cause a build-up of calcium, or may otherwise inhibit the blood's normal function. As a result, thromboembolism and hemolysis may occur. Additionally, the lining of an artificial heart or a ventricular assist device can crack, which inhibits performance, even when the crack is at a microscopic level. Such drawbacks have limited the use of artificial heart and assist devices to applications having too brief of a time period to provide a real lasting health benefit to the patient.
  • [0006]
    An alternative procedure also involves replacement of the heart, but includes a transplant of a natural heart from another human or animal into the patient. The transplant procedure requires removing an existing organ (i.e. the natural heart) from the patient for substitution with anotherorgan (i.e. another natural heart) from another human, or potentially, from an animal. Before replacing an existing organ with another, the substitute organ must be “matched” to the recipient, which can be, at best, difficult, time consuming, and expensive to accomplish. Furthermore, even if the transplanted organ matches the recipient, a risk exists that the recipient's body will still reject the transplanted organ and attack it as a foreign object. Moreover, the number of potential donor hearts is far less than the number of patients in need of a natural heart transplant. Although use of animal hearts would lessen the problem of having fewer donors than recipients, there is an enhanced concern with respect to the rejection of the animal heart.
  • [0007]
    Rather than replacing the patient's heart, other solutions attempt to continue to use the existing heart and associated tissue. In one such solution, attempts have been made to wrap skeletal muscle tissue around the natural heart to use as an auxiliary contraction mechanism so that the heart may pump. As currently used, skeletal muscle cannot alone typically provide sufficient and sustained pumping power for maintaining circulation of blood through the circulatory system of the body. This is especially true for those patients with severe heart failure.
  • [0008]
    Another system developed for use with an existing heart for sustaining the circulatory function and pumping action of the heart, is an external bypass system, such as a cardiopulmonary (heart-lung) machine. Typically, bypass systems of this type are complex and large, and, as such, are limited to short term use, such as in an operating room during surgery, or when maintaining the circulation of a patient while awaiting receipt of a transplant heart. The size and complexity effectively prohibit use of bypass systems as a long term solution, as they are rarely portable devices. Furthermore, long term use of a heart-lung machine can damage the blood cells and blood borne products, resulting in post surgical complications such as bleeding, thromboembolism function, and increased risk of infection.
  • [0009]
    Still another solution for maintaining the existing natural heart as the pumping device involves enveloping a substantial portion of the natural heart, such as the entire left and right ventricles, with a pumping device for rhythmic compression. That is, the exterior wall surfaces of the heart are contacted and the heart walls are compressed to change the volume of the heart and thereby pump blood out of the chambers. Although somewhat effective as a short term treatment, the existing pumping devices have not been suitable for long term use.
  • [0010]
    Typically, with such compression devices, heart walls are concentrically compressed. A vacuum pressure is then needed to overcome cardiac tissue/wall stiffness, so that the compressed heart chambers can return to their original volume and refill with blood. This “active filling” of the chambers with blood limits the ability of the pumping device to respond to the need for adjustments in the blood volume pumped through the natural heart, and can adversely affect the circulation of blood to the coronary arteries. Furthermore, natural heart valves, between the chambers of the heart and leaching into and out of the heart, are quite sensitive to wall distortion and annular distortion. The compressive movement patterns that reduce a chamber's volume and distort the heart walls may not necessarily facilitate valve closure (which can lead to valve leakage).
  • [0011]
    Therefore, mechanical pumping of the heart, such as through mechanical compression or distortion of the ventricles, must address these issues and concerns in order to establish the efficacy of long term mechanical or mechanically-assisted pumping. Specifically, the ventricles must rapidly and passively refill at low physiologic pressures, and the valve functions must be physiologically adequate. The myocardial blood flow of the heart also must not be impaired by the mechanical device. Still further, the left and right ventricle pressure independence must be maintained within the heart.
  • [0012]
    The present invention addresses the issues of heart wall stiffness and the need for active refilling by assisting in the bending (i.e., indenting, flattening, twisting, etc.) of the heart walls, rather than concentrically compressing the heart walls. Because of the mechanics of deformation in hearts having proportions typical in heart failure (specifically, wall thickness/chamber radius ratios), the deformation from bending and the subsequent refilling of the heart requires significantly less energy than would the re-stretching of a wall that has been shortened to change the chamber volume a similar amount. The present invention facilitates such desirable heart wall bending and specifically protects the heart wall during such bending.
  • [0013]
    Another major obstacle with long term use of such pumping devices is the deleterious effect of forceful contact of different parts of the living internal heart surface (endocardium), one against another, due to lack of precise control of wall actuation. In certain cases, this coaptation of endocardium tissue is probably necessary for a device that encompasses both ventricles to produce independent output pressures from the left and right ventricles. However, it can compromise the integrity of the living endothelium.
  • [0014]
    Mechanical ventricular wall actuation has shown promise, despite the issues noted above. As such, devices have been invented for mechanically assisting the pumping function of the heart, and specifically for externally actuating a heart wall, such as a ventricular wall, to assist in such pumping functions.
  • [0015]
    Specifically, U.S. Pat. No. 5,957,977, which is incorporated herein by reference in its entirety, discloses an actuation system for the natural heart utilizing internal and external support structures. That patent discloses an internal and external framework mounted internally and externally with respect to the natural heart, and an actuator element or activator mounted to the framework for providing cyclical forces to deform one or more walls of the heart, such as the left ventricular wall. The invention of U.S. patent application Ser. No. 09/850,554, which is also incorporated herein by reference in its entirety, further adds to the art of U.S. Pat. No. 5,957,977 and specifically sets forth various embodiments of activators or actuator elements which are suitable for deforming the heart walls and supplementing and/or providing the pumping function for the natural heart.
  • [0016]
    The actuation provided by such systems uses mechanical elements which engage, act upon and shape a portion of a heart wall. The heart wall is living tissue and, therefore, a concern with such heart wall actuation systems is the prevention of damage to the heart tissue during actuation. Specifically, it is desirable to prevent significant trauma to the outer tissue surfaces of the heart walls acted upon by the actuator elements.
  • [0017]
    It is therefore an objective of the present invention to further assist in the operation of such systems with the natural heart.
  • [0018]
    Specifically, it is an objective of the invention to prevent damage to the tissue of the heart, and particularly to prevent damage to the outer heart surface due to abrasion, pinching or other trauma to the heart associated with a heart wall actuation system.
  • [0019]
    It is still another objective of the present invention to provide long term actuation and assistance for the heart by reducing friction on the heart wall from a heart wall actuation system.
  • [0020]
    It is a further objective of the present invention to encourage the creation of a layer of flexible fibrous or scar tissue on the heart for further protection of the heart with a heart wall actuation system.
  • [0021]
    These objectives and other objectives are addressed by the invention as described and claimed below.
  • SUMMARY OF THE INVENTION
  • [0022]
    An actuation system for assisting the operation of the natural heart includes a framework for interfacing with the natural heart, an actuator element adapted to be coupled to the framework, and a protective sheath which is configured to extend along the heart wall between the actuator element and a heart wall portion for protecting the heart wall from damage by the action of the actuator element. More specifically, a framework interfaced with the natural heart includes elements which are configured for being anchored to tissue of the heart. An actuator element is configured to extend along a portion of the heart wall exterior surface and indent a portion of the heart wall to effect a reduction in the volume of one or more chambers of the heart and assist its pumping action.
  • [0023]
    Such movement along the heart wall and the forces introduced by the actuator element may provide friction, abrasion, pinching, or other trauma to the heart wall, and specifically to the tissue of the outer surface of the heart. The invention utilizes a protective sheath to extend along the heart wall between the actuator element and absorb any abrasion, pinching, or friction forces of the actuator element, to thereby prevent damage to the heart. The protective sheath is flexible and is operable to transmit, to the actuated heart wall portion, a force thereon for indenting the heart wall portion. That is, the forces of the actuator element generally tangent to the heart wall are absorbed, while those forces having components which are normal to the heart wall are transmitted for indenting the heart wall portion and assisting the pumping function of the heart by reducing the volume of one or more heart chambers.
  • [0024]
    In one embodiment of the invention, the protective sheath is a porous sheath formed by a plurality of interlocking elements formed of an abrasion-resistant material, such as a metal material, or an abrasion-resistant polymer. The interlocked elements may be utilized to form ring-shaped structures, such as to provide a “chain-mail effect” over the surface of the heart.
  • [0025]
    In another embodiment of the invention, the protective sheath includes a fabric jacket with a plurality of studs interspersed throughout the fabric. The stud surfaces are generally co-extensive with the surfaces of the fabric. The studs have rounded surfaces on at least one surface of the fabric, such as the one positioned outwardly from the heart surface and which is engaged by an actuator element. In that way, the protective sheath provides smooth operation of the actuator element against the heart wall, while preventing damage to the heart wall and translating forces from the actuator element to the chamber which is being actuated. The studs are formed of a suitable rugged and wear-resistant material, such as a metal, ceramic, or an abrasion-resistant polymer.
  • [0026]
    In still another embodiment of the invention, the protective sheath includes a net of woven, abrasion-resistant cords which are intermeshed to form the sheath. The cords forming the net are made of a suitable abrasion-resistant material such as metal, or an abrasion-resistant polymer.
  • [0027]
    Further features and benefits of the invention are set forth hereinbelow in the Detailed Description of Embodiments of the Invention.
  • BRIEF DESCRIPTION OF THE FIGURES
  • [0028]
    The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with a general description of the invention given below, serve to explain the principles of the invention.
  • [0029]
    [0029]FIG. 1A is a perspective view of one embodiment of the invention illustrated on a natural human heart.
  • [0030]
    [0030]FIGS. 1B and 1C are cross-sectional views which illustrate the embodiment of the invention shown in FIG. 1A with a heart wall actuation system in a relaxed and an actuated state, respectively.
  • [0031]
    [0031]FIG. 2A is a perspective view of an alternative embodiment of the invention illustrated on a natural human heart.
  • [0032]
    [0032]FIGS. 2B and 2C are cross-sectional views which illustrate the alternative embodiment of the invention shown in FIG. 2A with a heart wall actuation system in a relaxed and an actuated state, respectively.
  • [0033]
    [0033]FIG. 3A is a perspective view of another alternative embodiment of the invention illustrated on a natural human heart.
  • [0034]
    [0034]FIGS. 3B and 3C are cross-sectional views which illustrate the alternative embodiment of the invention shown in FIG. 3A with a heart wall actuation system in a relaxed and an actuated state, respectively.
  • DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION
  • [0035]
    The present invention may best be described in the context of the natural human heart, and accordingly, the heart structure is discussed briefly herein. Furthermore, the present invention is utilized in conjunction with a heart wall actuation system. One such actuation system, is described in U.S. patent application Ser. No. 09/850,554, which application is incorporated herein by reference in its entirety. Another suitable actuation system for practicing the invention is disclosed in greater detail in U.S. Pat. No. 5,957,977, which patent is incorporated herein by reference in its entirety. Other actuation systems may also be suitable. A brief overview of one type of actuation system for practicing the invention and of a framework for such a system is set forth herein.
  • [0036]
    An understanding of the heart is helpful in understanding the invention, and the heart and various of its components are described herein. Referring now to FIGS. 1A, 2A and 3A, a natural human heart 10 is shown in perspective with a portion of a framework of a suitable actuation system and various embodiments of protective sheaths. Heart 10 has a lower portion comprising two chambers, namely a left ventricle 12 and a right ventricle 14, which function primarily to supply the main pumping forces that propel blood through the circulatory system, including the pulmonary system (lungs) and the rest of the body, respectively. Heart 10 also includes an upper portion having two chambers, a left atrium 16 and a right atrium 18, which primarily serve as entryways to the ventricles 12 or 14, and also assist in moving blood into the ventricles 12 or 14. The interventricular wall or septum of cardiac tissue separating the left and right ventricles 12 and 14, is defined externally by an interventricular groove 20 on the exterior wall of the natural heart 10. The atrioventricular wall of cardiac tissue separating the lower ventricular region from the upper atrial region is defined by atrioventricular groove 22 on the exterior wall of the natural heart 10. The configuration and function of the heart is known to those of ordinary skill in this art.
  • [0037]
    Generally, the ventricles are in fluid communication with their respective atria through an atrioventricular valve in the interior volume defined by heart 10. More specifically, the left ventricle 12 is in fluid communication with the left atrium 16 through the mitral valve, while the right ventricle 14 is in fluid communication with the right atrium 18 through the tricuspid valve. Generally, the ventricles are in fluid communication with the circulatory system (i.e., the pulmonary and peripheral circulatory system) through semilunar valves. More specifically, the left ventricle 12 is in fluid communication with the aorta 26 of the peripheral circulatory system, through the aortic valve, while the right ventricle 14 is in fluid communication with the pulmonary artery 28 of the pulmonary, circulatory system through the pulmonic or pulmonary valve.
  • [0038]
    The heart basically acts like a pump. The left and right ventricles are separate, but share a common wall, or septum. The left ventricle has thicker walls and pumps blood into the systemic circulation of the body. The pumping action of the left ventricle is more forceful than that of the right ventricle, and the associated pressure achieved within the left ventricle is also greater than in the right ventricle. The right ventricle pumps blood into the pulmonary circulation, including the lungs. During operation, the left ventricle fills with blood in the portion of the cardiac cycle referred to as diastole. The left ventricle then ejects any blood in the part of the cardiac cycle referred to as systole. The volume of the left ventricle is largest during diastole, and smallest during systole. The heart chambers, particularly the ventricles, change in volume during pumping.
  • [0039]
    By way of a non-limiting example, the present invention is discussed in terms of use with a heart wall actuation system to assist in the actuation and operation of the left ventricular portion of the heart 10. However, it is noted that the present invention can also be used for the actuation and operation of other portions of the natural heart 10, such as the individual atria, the right ventricular portion of the heart 10, or simultaneously both atria or both ventricles. The present invention protects the portion of the heart engaged by an actuation system.
  • [0040]
    In accordance with illustrating an example of use of the invention with the left ventricular portion of the heart, a framework is discussed which positions one possible actuator system on the exterior surface or epicardium of the left ventricle. The invention may also be used on other surfaces of the heart. Also, other actuation systems may be used with the invention other than the one illustrated in the drawings.
  • [0041]
    Part of the framework is illustrated in FIGS. 1A, 2A, and 3A by reference numeral 70, which refers to an external component or yoke of the framework. The framework also includes internal framework elements (not shown) including an internal stint to which the external yoke or external framework element 70 is fixed by transmural cords which extend through walls of the heart. The internal stint is sized and configured for placement within the interior volume of the natural heart 10, generally alongside the right side of the interventricular septum. The stint also includes at least two separate ring structures (not shown) for positioning proximate the valve annuli of the left side of the heart. Further details of suitable frameworks are set forth in U.S. Pat. No. 5,957,977, and pending U.S. patent application Ser. No. 09/850,554.
  • [0042]
    As illustrated in FIGS. 1A, 2A, and 3A, the framework also includes the external yoke 70 which is configured for placement around a portion of the exterior surface or epicardium of a natural heart 10. The generally stirrup-shaped yoke 70 in the illustrated embodiment restricts free motion of the natural heart 10 so that the natural heart 10 can be actuated and assisted. Yoke 70 also acts as an anchor for an appropriate actuator element or system for use with the invention. In one embodiment, the yoke 70 is between about 1 and 2 cm wide and includes a semi-rigid collar portion, preferably made of either a solid polymer of appropriate mechanical behavior, such as polypropylene or polyacetal, or a composite of metal (stainless steel or pure titanium) band or coil spring elements, polymer fabric and fiber (e.g. polyester knit) and soft elastomer, for providing rigidity to the yoke 70. Additionally, the yoke 70 may include a gel-filled cushion portion 80 that is positioned immediately adjacent the exterior surface (epicardium) of the natural heart 10 for providing equalized pressure over the irregularities in the epicardial surface of the heart 10, and any of the coronary arteries 30 within a region under the yoke 70. Preferably, the yoke 70 is sized and configured for placement adjacent at least a portion of the atrioventricular groove 22, and simultaneously adjacent at least a portion of the anterior and posterior portions of the interventricular groove 20, and most preferably, adjacent at least a substantial portion of the anterior and posterior portion of the interventricular groove 20, as shown in FIGS. 1A, 2A, and 3A.
  • [0043]
    General alignment of the yoke 70 with interior framework elements is maintained by at least one transmural cord (not shown), and preferably, a plurality of cords that penetrate the walls of the natural heart 10 and connect to the internal stint and one or more of the internal rings, as noted above and discussed in U.S. Pat. No. 5,957,977.
  • [0044]
    Referring now to FIG. 1A, an actuation system 82 is illustrated for assisting the operation of the natural heart 10. The actuation system 82 incorporates a framework for interfacing with the natural heart, as discussed above. One visual external element of a suitable framework is the yoke 70, as illustrated in FIG. 1A. Yoke 70 is anchored to tissue of the heart, such as through an internal framework element or elements, as discussed above. The yoke element 70 is anchored in position on heart 10 to provide support for an actuator device or element. As illustrated in the figures, the actuation system of the invention, and particularly the protective sheath 84, are shown coupled to the left ventricle of the heart. However, as will be understood by a person of ordinary skill in the art, the invention may be utilized with other chambers of the heart, such as the left atrium, or the right side of the heart, including the right atrium and/or the right ventricle. Therefore, the invention is shown positioned for the purposes of illustration only, and its illustrated position is not meant to be limiting to the usefulness of the invention.
  • [0045]
    For actuating a wall of the heart, such as to cyclically deform or shape the wall of the heart, change the volume of a heart chamber, and assist in the pumping action, the actuator system includes an actuator element or device which is adapted to be coupled to the framework, such as yoke 70. One possible actuator element 86 is shown in the Figures, but is not meant to be limiting. The actuator element 86 is configured for extending along, or proximate to, a portion of the heart wall exterior surface, such as the exterior surface 96 of the left ventricle. Actuator element 86 is operable for indenting or shaping the portion of the heart wall to effect a reduction in the volume of the heart and thereby assist in the pumping of blood through the heart. In the illustrated embodiment, the actuator element 86 comprises an actuator band extending along a portion of the heart wall and selectively movable between a relaxed state and an actuated state, as illustrated in FIGS. 1B and 1C, respectively. When in the actuated state, the band 86 assumes a predetermined shape, as illustrated in FIG. 1C, and thereby indents the protective sheath 84 of the invention, and indents a portion of the heart wall underlying the protective sheath to affect a reduction in the volume of the heart for a particular heart chamber (e.g., the left ventricle). Actuator band 86 includes a plurality of juxtaposed blocks 88 configured to be drawn together and to cooperate with each other, when drawn together, to assume a predetermined shape. In the Figures, and particularly FIGS. 1C, 2C, and 3C, the band is shown to take a generally flat shape in contrast to the relaxed curved shape which follows the natural curves of the heart. However, the band might be made to take various shapes when actuated, as shown in U.S. patent application Ser. No. 09/850,554.
  • [0046]
    For actuating the element 86, the blocks include a passage 90 formed therethrough, made up of individual passages through the respective blocks 88. A cable structure 92 extends through the passage and is coupled at one end to an anchor point, such as to the framework element, or yoke 70. Drawing cable 92 through the passage 90 draws the blocks together so that the blocks cooperate with each other as illustrated in FIG. 1C, to assume the desired predetermined shape of the actuated band. The band 86 acts on the heart wall and indents the heart wall to effect a reduction in volume of the heart chamber. For example, band 86 may provide an inward force on the heart wall. As shown between FIGS. 1B and 1C, the actuator blocks 88 also slide or move along the heart wall surface in the actuated state. This presents a fixation force on the heart wall, generally normal to the wall surface 96. Such an actuator system is illustrated in greater detail in U.S. patent application Ser. No. 09/850,554.
  • [0047]
    In accordance with another aspect of the present invention, protective sheath 84 is configured to extend along a portion of the heart wall, such as the outer wall of the left ventricle, as illustrated in the figures. The protective sheath 84 extends along the wall and is positioned between the actuator element 86 and the heart wall surface 96 for protecting the heart wall surface 96 from damage by the actuator element. The protective sheath is flexible, and is operable to transmit, to the heart wall portion, a force thereon by the actuator element for indenting the heart wall portion. More specifically, in the illustrated embodiment of the actuator element 86, the blocks 88 move against heart wall portion 94 as the actuator element moves between a relaxed and actuated position. The heart wall portion 94 and tissue associated therewith, are forcibly indented and deformed due to the action of the actuator element 86. Furthermore, friction exists between heart wall portion 94 (i.e., surface 96) and the moving blocks 88. The protective sheath 86 protects the tissue of the heart wall portion 94 to prevent damage of that tissue. Simultaneously, the forces for shaping and deforming the wall portion 94 are transmitted through the flexible protective sheath 84. The sheath provides a paving feature which absorbs the friction of the movement of the actuator elements, such as the individual blocks 88, and protects the heart surface 96 from abrasion, pinching, or other trauma associated with the action of the actuator element 86. For example, pinching of the heart wall tissue may be a specific concern with the actuator element 86 illustrated herein.
  • [0048]
    The protective sheath also helps to blunt any trauma to the heart tissue caused by the actuator element and helps spread the indenting forces smoothly over the heart wall surface 96.
  • [0049]
    In one embodiment of the invention, the protective sheath 84 is generally porous and may include openings which encourage the ingrowth of a layer of flexible fibrous, or scar tissue, which intermeshes with sheath 84 and extends the overall protective effect of the invention.
  • [0050]
    FIGS. 1A-1C illustrate one particular embodiment of the invention. Specifically, the protective sheath 84 includes a plurality of interlocked elements 100. As illustrated in FIG. 1A, the interlocked elements 100 essentially form individual ring structures, as illustrated by reference numeral 102. In such an embodiment, the protective sheath 84 resembles “chain-mail” armor which may move freely in all directions so that the heart may be actuated readily in all directions.
  • [0051]
    The protective sheath 84 may be held in position on the heart with tissue adhesives, sutures, or other means commonly used for tissue-to-prosthesis fixation. That is, it may be just wrapped around the heart. Alternatively, the sheath 84 may be fixed to a framework element, such as yoke 70 and/or to the actuator element 86. The material making up the interlocked elements 100 may be formed of a suitable metal, such as stainless steel 316 or CP titanium, for providing low friction and wear resistance. An alternative material for the interlocked elements 100 might include a ceramic, highly abrasion-resistant polymer, such as polyacetal (e.g., a material often referred to as Delrin™) or polyethylene, particularly ultra-high molecular weight polyethylene, or UHMWFE. Other materials may be nickel-titanium alloys or other shape memory components, such as, for example, Nitinol™. Alternatively, the interlocked elements might be formed of a combination of such materials wherein alternating elements are made of different materials.
  • [0052]
    [0052]FIGS. 2A, 2B, and 2C illustrate another embodiment of the invention, and are illustrated similarly to FIGS. 1A-1C. That is, FIG. 2A shows the alternative embodiment of the protective sheath mounted on a human heart with a suitable framework. FIGS. 2B and 2C illustrate one possible actuator element to be utilized with the protective sheath, in both a relaxed and actuated position, respectively. Similar reference numerals are utilized for similar elements previously described in FIGS. 1A-1C.
  • [0053]
    Protective sheath 86 a includes a net of woven or knit, abrasion-resistant cords or threads. As illustrated in FIG. 2B, for example, transverse cords 104, cooperate with longitudinal cords 106 to form the net. The net might be woven or knitted in various other suitable ways known to those of ordinary skill in the art, and the embodiment of the invention is not limited to the woven structure illustrated in the drawings. Protective sheath 86 a provides an abrasion-resistant net for protecting the tissue of the heart, as discussed above, while providing the translation of necessary forces to the heart from the actuation system. The actuator element 86, and particularly the blocks 88 may readily move on the net 86 a for forming and shaping the heart wall portion 94. As noted, the woven net 86 a provides a paving action and absorbs friction of movement of the blocks 88 while protecting the heart surface 96 from abrasion, pinching, and other trauma.
  • [0054]
    In one embodiment of the invention, the net 86 a is formed of cords 104, 106 which are made of an abrasion resistant material, such as a suitable metal, including stainless steel 316 or CP titanium, nickel-titanium alloys, ceramics, or shape memory materials. Another suitable material for the cords 104, 106 forming the protective net 86 a is an abrasion resistant polymer, such as linearly crystalline polyethylene, sometimes referred to by the trademark Spectra™. A combination of the various materials might also be used.
  • [0055]
    In one embodiment, the cables or cords (e.g. cords 106) on the actuator-facing surface, or their component fibers, are oriented parallel to the direction of tangential motion of the actuator element 86, such as the motion of blocks 88. For example, referring to FIGS. 2B and 2C, the block 88 would generally move tangentially in the direction of arrows 89 when actuated. With the cords 106 oriented generally parallel with that direction, friction may be reduced to make a smoother surface. This may, in turn, reduce both material damage from wear and energy loss from friction. The cords may be so oriented using available textile design and manufacturing techniques as known to those of ordinary skill in the art. While the actuator 86 of the Figures shows one possible embodiment, other embodiments might have elements moving in other tangential directions than direction 89. In accordance with the invention, other cords, such as cords 104, might be oriented generally parallel to such other tangential motion.
  • [0056]
    [0056]FIGS. 3A, 3B, and 3C illustrate another alternative embodiment of the invention, and like reference numerals are utilized for like elements, as discussed above.
  • [0057]
    A protective sheath 86 b includes a fabric jacket 108, with a plurality of studs 110 interspersed throughout the fabric jacket 108. Referring to FIGS. 3B and 3C, the studs 110 have stud surfaces 112 on either side thereof, and the stud surfaces are generally co-extensive with surfaces of the fabric 108. In that way, the combination of fabric jacket and studs forms an overall protective sheath 86 b. In accordance with one aspect of the present invention, the surfaces 112 a of the studs, which are positioned away from the heart, are rounded. With the outer rounded surfaces 112 a, the blocks 88 of the actuator element 86 slide freely over the protective sheath 84 b and the sheath prevents damage to the heart tissue associated with the actuation of the heart wall.
  • [0058]
    Suitable materials for the studs include suitable metals, such as stainless steel 316 or CP titanium. A ceramic, such as pyrolytic carbon would also be suitable. Furthermore, a wear-resistant polymer, such as a polyacetal (e.g., Delrin™, as noted above) or ultra-high molecular weight polyethylene (UHMWPE) may also be utilized.
  • [0059]
    The fabric jacket may be formed of a biocompatible material, such as a woven, knit, or braided material of polyester, linearly crystalline polyethylene (Spectra™), or polytetrafluoroethylene. Alternatively, an absorbable polymeric fabric, such as an oxidized cellulose or polyglycolic acid might be utilized.
  • [0060]
    The protective sheath 84 b operates similarly to the other embodiments of the protective sheath discussed above to translate forces in motion of the actuator element to heart wall portion 94 without damaging the tissue of heart surface 96.
  • [0061]
    The present invention provides a significant benefit when utilized with heart wall actuating elements and systems by providing a protective paving structure which allows elements of the heart wall actuating system to slide on the surface of the heart in the directions which are generally tangent to the surface 96 of the heart wall and the surface created by the protective sheath. Simultaneously, the protective sheath is flexible, and is operable to transmit any translational or inward movement of the actuator elements in directions which have force components generally normal to the heart surface 96 and normal to the protective sheath, such as in the direction of reference arrow 120 in FIG. 1B.
  • [0062]
    The protective sheath of the invention may be anchored to the framework, such as framework element 70 for providing the desired protection of the heart wall which is being actuated. Alternatively, as noted above, the protective sheath could be individually coupled, such as by adhesive or sutures to the heart wall.
  • [0063]
    The porosity of the protective sheath is a desirable characteristic, as it may allow and/or encourage ingrowth of a layer of a flexible, fibrous or scar tissue with the protective sheath which expands and extends the protective effect of the invention. However, the growth of such a layer is not critical to the invention, as the invention alone will provide the desired protection of the actuated heart wall.
  • [0064]
    While the present invention has been illustrated by the description of the embodiments thereof, and while the embodiments have been described in considerable detail, it is not the intention of the applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. Therefore, the invention in its broader aspects is not limited to the specific details representative apparatus and method, and illustrative examples shown and described. Accordingly, departures may be made from such details without departure from the spirit or scope of applicant's general inventive concept.
Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US2826193 *1 août 195611 mars 1958Vineberg Heart FoundationCardiac resuscitation device
US3053249 *25 août 195911 sept. 1962Gorman Rupp Ind IncCardiac massage apparatus
US3455298 *10 avr. 196715 juil. 1969Anstadt George LInstrument for direct mechanical cardiac massage
US3513836 *5 sept. 196726 mai 1970Andre SausseProsthesis for cardiac assistance
US3590815 *7 janv. 19696 juil. 1971Shiff PeterPortable mechanical ventricular assistance device
US3613672 *9 juil. 196919 oct. 1971Schiff PeterMechanical ventricular assistance cup
US3668708 *23 déc. 196913 juin 1972North American RockwellArtificial heart
US3713439 *26 févr. 197130 janv. 1973Cabezudo JMassage envelope belt with adjusting dispositives for vibrators and mobilizers
US3827426 *16 juil. 19716 août 1974Page MProsthetic pump
US3983986 *5 nov. 19745 oct. 1976Automatisme Et TechniqueCirulating conveyor
US4192293 *5 sept. 197811 mars 1980Manfred AsricanCardiac assist device
US4536893 *7 nov. 198427 août 1985Roberto ParraviciniImplant device for substaining the activity of the myocardium
US4621617 *1 juin 198211 nov. 1986Sharma Devendra NElectro-magnetically controlled artificial heart device for compressing cardiac muscle
US4690134 *1 juil. 19851 sept. 1987Snyders Robert VVentricular assist device
US4846831 *27 avr. 198811 juil. 1989Skillin David EManual back-up drive for artificial heart
US4904255 *16 déc. 198627 févr. 1990Aerospatiale Societe Nationale IndustrielleComplete artificial heart with two pumping modules connected together by a functional connection
US5109843 *30 nov. 19905 mai 1992University Of CincinnatiExtra to-intracorporeal power supply
US5119804 *19 nov. 19909 juin 1992Anstadt George LHeart massage apparatus
US5131905 *16 juil. 199021 juil. 1992Grooters Ronald KExternal cardiac assist device
US5139517 *26 juil. 199118 août 1992Corral David FOrthotopic intraventricular heart pump
US5201880 *27 janv. 199213 avr. 1993Pioneering Technologies, Inc.Mitral and tricuspid annuloplasty rings
US5256132 *17 août 199226 oct. 1993Snyders Robert VCardiac assist envelope for endoscopic application
US5258021 *27 janv. 19922 nov. 1993Duran Carlos GSigmoid valve annuloplasty ring
US5334217 *14 mai 19932 août 1994Regents Of The University Of MinnesotaSeptal defect closure device
US5358519 *15 juil. 199325 oct. 1994Medtronic, Inc.Muscle control and monitoring system
US5370685 *16 juil. 19916 déc. 1994Stanford Surgical Technologies, Inc.Endovascular aortic valve replacement
US5383840 *28 juil. 199224 janv. 1995Vascor, Inc.Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly
US5487760 *8 mars 199430 janv. 1996Ats Medical, Inc.Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry
US5533958 *5 août 19949 juil. 1996Wilk; Peter J.Intrapericardial assist device and associated method
US5702343 *2 oct. 199630 déc. 1997Acorn Medical, Inc.Cardiac reinforcement device
US5713954 *13 juin 19953 févr. 1998Abiomed R&D, Inc.Extra cardiac ventricular assist device
US5800528 *29 déc. 19951 sept. 1998Abiomed R & D, Inc.Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US5957977 *2 janv. 199628 sept. 1999University Of CincinnatiActivation device for the natural heart including internal and external support structures
US6183411 *21 sept. 19986 févr. 2001Myocor, Inc.External stress reduction device and method
US6332864 *27 oct. 200025 déc. 2001Myocor, Inc.Heart wall tension reduction apparatus
US6547821 *16 juil. 199815 avr. 2003Cardiothoracic Systems, Inc.Surgical procedures and devices for increasing cardiac output of the heart
US6684404 *15 août 20013 févr. 2004Second Chance Body Armor, Inc.Multi-component stab and ballistic resistant garment and method
US20020007216 *7 mai 200117 janv. 2002Melvin David BoydHeart wall actuation device for the natural heart
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US7174896 *7 janv. 200313 févr. 2007Paracor Medical, Inc.Method and apparatus for supporting a heart
US7476249 *3 août 200513 janv. 2009Frank Robert EImplantable prosthesis for positioning and supporting a breast implant
US76662247 juil. 200523 févr. 2010Edwards Lifesciences LlcDevices and methods for heart valve treatment
US76781451 juil. 200516 mars 2010Edwards Lifesciences LlcDevices and methods for heart valve treatment
US769542517 févr. 200413 avr. 2010Edwards Lifesciences LlcHeart wall tension reduction apparatus and method
US77225239 juil. 200225 mai 2010Edwards Lifesciences LlcTransventricular implant tools and devices
US776681214 avr. 20063 août 2010Edwards Lifesciences LlcMethods and devices for improving mitral valve function
US800753129 nov. 200630 août 2011Frank Robert EImplantable prosthesis for positioning and supporting a breast implant
US807080525 janv. 20106 déc. 2011Edwards Lifesciences LlcDevices and methods for heart valve treatment
US818732319 oct. 200129 mai 2012Edwards Lifesciences, LlcValve to myocardium tension members device and method
US82267111 juil. 200524 juil. 2012Edwards Lifesciences, LlcValve to myocardium tension members device and method
US8235884 *3 janv. 20077 août 2012John W RoyaltyCardiac tissue energy dispersion device
US846987412 oct. 200925 juin 2013Milux Holding SaHeart help device, system, and method
US85066242 déc. 201113 août 2013Edwards Lifesciences, LlcDevices and methods for heart valve treatment
US8509894 *12 oct. 200913 août 2013Milux Holding SaHeart help device, system, and method
US85453841 févr. 20101 oct. 2013Obtech Medical AgAnal incontinence disease treatment with controlled wireless energy supply
US855679615 janv. 201015 oct. 2013Obtech Medical AgControlled urinary incontinence treatment
US86005109 oct. 20093 déc. 2013Milux Holding SaApparatus, system and operation method for the treatment of female sexual dysfunction
US860296625 avr. 200810 déc. 2013Obtech Medical, AGMechanical impotence treatment apparatus
US863680929 janv. 200928 janv. 2014Milux Holding SaDevice for treating obesity
US867899714 mars 200625 mars 2014Obtech Medical AgMale impotence prosthesis apparatus with wireless energy supply
US869674512 oct. 200915 avr. 2014Kirk Promotion Ltd.Heart help device, system, and method
US873431828 juin 200627 mai 2014Obtech Medical AgMechanical anal incontinence
US876462710 sept. 20081 juil. 2014Obtech Medical AgPenile prosthesis
US88742159 oct. 200928 oct. 2014Peter ForsellSystem, an apparatus, and a method for treating a sexual dysfunctional female patient
US896144828 janv. 200924 févr. 2015Peter ForsellImplantable drainage device
US900510421 juin 201314 avr. 2015Peter ForsellHeart help device, system, and method
US906077129 janv. 200923 juin 2015Peter ForsellMethod and instrument for treating obesity
US907290712 oct. 20097 juil. 2015Peter ForsellHeart help device, system, and method
US91987577 juil. 20091 déc. 2015Edwards Lifesciences, LlcMethods and devices for improving mitral valve function
US937065625 août 201421 juin 2016Peter ForsellSystem, an apparatus, and a method for treating a sexual dysfunctional female patient
US949227012 sept. 200815 nov. 2016Alan Joel MelvinMedical device and tension member for use in a subject
US952664929 janv. 200927 déc. 2016Peter ForsellMethod and instrument for treating obesity
US9694165 *20 févr. 20154 juil. 2017Peter Mats ForsellImplantable drainage device
US20020029080 *19 oct. 20017 mars 2002Myocor, Inc.Valve to myocardium tension members device and method
US20020169359 *2 mai 200214 nov. 2002Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20030032979 *9 juil. 200213 févr. 2003Myocor, Inc.Transventricular implant tools and devices
US20030181928 *10 avr. 200325 sept. 2003Myocor, Inc.Endovascular splinting devices and methods
US20030233022 *9 juin 200318 déc. 2003Vidlund Robert M.Devices and methods for heart valve treatment
US20040148019 *10 nov. 200329 juil. 2004Vidlund Robert M.Devices and methods for heart valve treatment
US20040148020 *10 nov. 200329 juil. 2004Vidlund Robert M.Devices and methods for heart valve treatment
US20050075723 *7 mai 20047 avr. 2005Myocor, Inc.Methods and devices for improving mitral valve function
US20050148815 *28 janv. 20057 juil. 2005Myocor, Inc.Transventricular implant tools and devices
US20060030939 *3 août 20059 févr. 2006Frank Robert EImplantable prosthesis for positioning and supporting a breast implant
US20060036317 *7 juil. 200516 févr. 2006Myocor, Inc.Decives and methods for heart valve treatment
US20060041306 *1 juil. 200523 févr. 2006Myocor, Inc.Devices and methods for heart valve treatment
US20060052868 *1 juil. 20059 mars 2006Myocor, Inc.Valve to myocardium tension members device and method
US20060149123 *7 mars 20066 juil. 2006Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US20060161040 *23 déc. 200520 juil. 2006Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20060195012 *14 avr. 200631 août 2006Myocor, Inc.Valve to myocardium tension members device and method
US20060241340 *14 avr. 200626 oct. 2006Myocor, Inc.Methods and devices for improving mitral valve function
US20060247491 *27 avr. 20052 nov. 2006Vidlund Robert MDevices and methods for heart valve treatment
US20070015959 *14 mars 200618 janv. 2007Obtech Medical AgMale impotence prosthesis apparatus with wireless energy supply
US20070073099 *28 juin 200629 mars 2007Obtech Medical AgMechanical anal incontinence
US20070088434 *29 nov. 200619 avr. 2007Frank Robert EImplantable prosthesis for positioning and supporting a breast implant
US20070238914 *3 janv. 200711 oct. 2007Royalty John WCardiac tissue energy dispersion device
US20080275296 *25 avr. 20086 nov. 2008Obtech Medical AgMechanical impotence treatment apparatus
US20090018388 *10 sept. 200815 janv. 2009Peter ForsellPenile prosthesis
US20090216252 *11 févr. 200527 août 2009The University Of CincinnatiA coupling device enabled by mechanical continuity of cellular scaffolding across tissue boundaries
US20090270980 *7 juil. 200929 oct. 2009Edwards Lifesciences LlcMethods and Devices for Improving Mitral Valve Function
US20100185276 *25 janv. 201022 juil. 2010Edwards Lifesciences LlcDevices and Methods for Heart Valve Treatment
US20100217067 *1 févr. 201026 août 2010Obtech Medical AgAnal incontinence disease treatment with controlled wireless energy supply
US20100298935 *12 sept. 200825 nov. 2010Surgical Energetics, Inc.Medical Device and Tension Member for Use in a Subject
US20100312164 *28 janv. 20099 déc. 2010Peter ForsellImplantable drainage device
US20100331616 *29 janv. 200930 déc. 2010Peter ForsellMethod and instrument for treating obesity
US20100332000 *29 janv. 200930 déc. 2010Peter ForsellDevice for treating obesity
US20110004053 *5 déc. 20086 janv. 2011Surgical Energetics, Inc.bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same
US20110015473 *19 juil. 201020 janv. 2011Teslux Holdings S.A.Vaginal operation method for the treatment of urinary incontinence in women
US20110196485 *12 oct. 200911 août 2011Peter ForsellHeart help device, system, and method
US20110196486 *12 oct. 200911 août 2011Milux Holdings SAHeart help device, system, and method
US20110201871 *12 oct. 200918 août 2011Milux Holding SaHeart help device, system, and method
US20110202041 *6 oct. 200918 août 2011Milux Holding SaFastening means for implantable medical control assembly
US20110202131 *12 oct. 200918 août 2011Milux Holding SaHeart help device, system, and method
US20110224787 *12 oct. 200915 sept. 2011Milux Holding SaHeart help device, system, and method
US20150157836 *20 févr. 201511 juin 2015Peter Mats ForsellImplantable drainage device
Classifications
Classification aux États-Unis600/16
Classification internationaleA61M1/10
Classification coopérativeA61M1/1068, A61M1/1056, A61M1/12, A61M1/1046
Classification européenneA61M1/10E50B
Événements juridiques
DateCodeÉvénementDescription
18 juil. 2002ASAssignment
Owner name: CINCINNATI, UNIVERSITY OF, THE, OHIO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MELVIN, DAVID BOYD;REEL/FRAME:013120/0870
Effective date: 20020506